ABT-737 synergizes with Bortezomib to kill melanoma cells. - Test2 - elhamkhani - TriplyDB

ABT-737 synergizes with Bortezomib to kill melanoma cells.

ABT-737 synergizes with Bortezomib to kill melanoma cells.

http://www.wikidata.org/entity/Q36425600

about

Alternative Treatments For Melanoma: Targeting BCL-2 Family Members to De-Bulk and Kill Cancer Stem Cells MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD)The ratio of Mcl-1 and Noxa determines ABT737 resistance in squamous cell carcinoma of the skin Therapeutic interventions to disrupt the protein synthetic machinery in melanoma Erdr1 Suppresses Murine Melanoma Growth via Regulation of Apoptosis.Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments.Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics.miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.Towards combinatorial targeted therapy in melanoma: from pre-clinical evidence to clinical application (review).Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cells Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells.Bcl‑2 associated athanogene 4 promotes proliferation, migration and invasion of gastric cancer cells.Proteasome inhibitors against amelanotic melanoma.Targeting the intrinsic apoptosis pathway as a strategy for melanoma therapy.

P2860

Q28084243-F5799C0C-29C4-4692-BFC9-FD53DC5EBB8C Q28280193-BD93BE92-C8B7-41C5-9273-D594C66B9C59 Q35966223-57AC5090-7EB7-4F6D-8DB6-A27D5B41C062 Q36473355-BE41EFBA-E341-46FF-8DC6-0C04ECD5AACF Q36512628-09D0E382-E379-44C0-89AE-0DA84F481871 Q37708989-A153629A-F778-4BBA-9D65-A0231BB21934 Q38127412-98F1F363-DE52-498C-AEB1-1B64DF9DD964 Q38138933-8CCA52A5-EB33-41EC-BEAE-B6B278FDEB57 Q38219616-2DF2AA44-E3DD-4322-8307-9891C275A05C Q38944587-46F895B5-9204-4426-9917-18EDF74C4CDD Q41470758-475ACEF2-BE4E-437D-A9E9-CADCF6B79A8E Q42679623-B2451124-28F1-4D70-BC74-75EC9B8EF5CB Q47141204-6DB898E1-5D33-4530-9AE4-65DEAA2E0CC0 Q51746852-DF09BB62-B9F5-40DD-8CF9-832C15E8E52E

P2860

ABT-737 synergizes with Bortezomib to kill melanoma cells.

http://www.wikidata.org/entity/Q36425600

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

ABT-737 synergizes with Bortezomib to kill melanoma cells.

@ast

ABT-737 synergizes with Bortezomib to kill melanoma cells.

@en

type

label

ABT-737 synergizes with Bortezomib to kill melanoma cells.

@ast

ABT-737 synergizes with Bortezomib to kill melanoma cells.

@en

prefLabel

ABT-737 synergizes with Bortezomib to kill melanoma cells.

@ast

ABT-737 synergizes with Bortezomib to kill melanoma cells.

@en

P1433

Q36425600-14D72A04-770A-4DB7-A0EF-DACE2D0B3BF1

P1476

Q36425600-EDB5DE97-9DBF-4B8E-AD7A-6C732E916CF2

P2093

Q36425600-170C2FBD-65C6-444C-BD7C-DE198C66B92D

Q36425600-2165C58B-DEC8-48AE-B834-489162728845

Q36425600-51719776-8489-4E92-B232-5BAF8A966738

Q36425600-5BFB5702-F908-42BB-8B2C-1A50DD3F7E9A

Q36425600-8712CE54-15DB-45B0-B35D-6582F2F5C6E7

Q36425600-A12A8BC5-C8B7-4D14-87B6-88C5EF0107DE

Q36425600-A22094B2-0048-4855-9878-1DBC70523711

Q36425600-BA6EEA52-9B8A-468A-9FF1-AA0906EA3217

Q36425600-CA5E8B85-ABAD-4724-B2D8-52F6E278B8CF

Q36425600-E438D801-756F-4653-AE24-4DCD647DAB16

P2860

Q36425600-15A884BE-BA1D-4EB3-A030-35EBAF794651

Q36425600-199ABF33-E827-48CD-AA1B-284B48A8EECD

Q36425600-202400DF-744A-4EF1-9B33-5EA9FDAB077D

Q36425600-220E7651-16F0-4D97-9893-29FA5D23503A

Q36425600-24555BF4-77BF-4CA8-A801-85E89CEB4EF9

Q36425600-258B4A98-D51D-4E96-A3F8-4EC5AE90D218

Q36425600-29379B75-44FD-4229-B230-4D55387BDDB3

Q36425600-308194D9-4D0B-4D40-80A6-CD795CD528B8

Q36425600-31755DFC-4D17-42FA-9E6D-746F903FC298

Q36425600-34B9416A-C6D8-4D8D-B1FE-6D343F1E37CB

P304

Q36425600-452E580C-DF9B-4DA8-A374-160723347025

P31

Q36425600-B6F9BB83-73C9-4484-832A-8C0EDBF4FEBA

P356

Q36425600-DE1A9C42-1753-40C5-A2CE-8CC265F4A894

P433

Q36425600-8F98A41E-EB5F-406E-A9CD-159614CAEEFC

P478

Q36425600-950E847D-F6A7-46C0-BED2-E3D7E4E892B8

P577

Q36425600-3EF2874B-E72C-4724-AF9D-07D58CBEABE3

P5875

Q36425600-5E4E6777-0975-4656-BFB6-35E4915D22C0

P698

Q36425600-388FCA48-CCE9-44A5-81AF-5A673974352C

P932

Q36425600-FF714675-AA3F-4F93-92F9-9FA0C9F78A8E

P356

P1433

P1476

ABT-737 synergizes with Bortezomib to kill melanoma cells.

@en

P2093

David A Norris

http://www.w3.org/2001/XMLSchema#string

Karl Lewis

http://www.w3.org/2001/XMLSchema#string

Katie A Partyka

http://www.w3.org/2001/XMLSchema#string

Mayumi Fujita

http://www.w3.org/2001/XMLSchema#string

Nathaniel B Goldstein

http://www.w3.org/2001/XMLSchema#string

Rene Gonzalez

http://www.w3.org/2001/XMLSchema#string

Shilo Smith

http://www.w3.org/2001/XMLSchema#string

Steven N Reuland

http://www.w3.org/2001/XMLSchema#string

Yiqun G Shellman

http://www.w3.org/2001/XMLSchema#string

Yuchun Luo

http://www.w3.org/2001/XMLSchema#string

P2860

Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function

Noxa/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cells

Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins.

Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members

Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737.

Advances in systemic treatment of melanoma.

Melanoma genetics and the development of rational therapeutics.

P304

92-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1242/BIO.2011035

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233850161

http://www.w3.org/2001/XMLSchema#string

P698

23213401

http://www.w3.org/2001/XMLSchema#string

P932

3507205

http://www.w3.org/2001/XMLSchema#string